DrugDashboards
← Home
Manufacturing facility

Gland Pharma Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Survey No. 143 - 148, 150 & 151, Near Gandimaisamma Cross Roads, D. P. Pally, Dundigal Post, Dundigal - Gandimaisamma Mandal, Medchal - Malkajgiri District, Hyderabad, Telangana 500043, India (IND)
Operations here
analysisapi manufacturelabelmanufacturepack
FDA identifiers
FEI 3002647489 · DUNS 918601238

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2024-07-25
  • VAIDrug Quality Assurance2023-07-14
  • VAIDrug Quality Assurance2019-05-16
  • VAIDrug Quality Assurance2017-02-03
  • VAIDrug Quality Assurance2015-03-17
  • VAIDrug Quality Assurance2012-09-07
  • NAIDrug Quality Assurance2011-01-07

Drugs this plant is listed as making

132 distinct drugs across 283 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.